Trial Search Results

Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy

SPECIFIC STUDY AIMS

1. To evaluate congruence between pelvic anatomical structures segmented on MRI and/or CT scans co-registered with transperineal US scans acquired with an optically and/or electromagnetically tracked matrix array ultrasound transducer.

2. To estimate the achievable accuracy of anatomy tracking based on 3D US matrix-array transducer imaging and grey-level based image registration algorithms.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: Philips Healthcare

Stanford Investigator(s):

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Men that will undergo prostate radiotherapy as a primary treatment or
   post-prostatectomy.

   - Age 18 or older

   - Ability to understand and sign informed consent

Exclusion Criteria:

   - Younger than 18 yrs old

   - Inability to provide written and spoken consent.

   - Patients with implanted actively controlled devices that may be subject to
   electromagnetic interference from the UroNav/PervuNav electromagnetic tracking used in
   the study.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Male

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
CCTO
650-498-7061